CIK 0001936258 · Large accelerated filer
NewAmsterdam Pharma Co N.V.
Sign in to watch- Ticker
- NAMS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Netherlands
- Entity type
- operating
- Phone
- 35 206 2971
- Business address
- GOOIMEER 2-35, NARRDEN, Netherlands, 1411 DC
- Former names
- NewAmsterdam Pharma Co B.V.
Securities
- NAMS Ordinary Shares Nasdaq
- NAMSW Warrant Nasdaq
- EFFECT Other Notice of Effectiveness
- 8-K Event Regulation FD disclosure
- SC 13D/A Stake Beneficial Ownership Report
- POS AM Other Post-effective Amendment for Registration Statement
- 8-K Event Results of operations
- 10-K Report Annual Report
- 4 Open-market buy Director bought 5,000 shares at $19.00 ($95,000)
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Material agreement · Regulation FD disclosure
- 424B5 Offering Prospectus
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 424B5 Offering Prospectus
- 3/A Insider 3/A
- 3/A Insider 3/A
- 8-K Event Regulation FD disclosure
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Regulation FD disclosure
- 8-K Event Regulation FD disclosure
Page 14 of 21 · 415 filings